Cart
sales@molnova.com
DMU2139
CAS No. 104890-70-2
DMU2139( —— )
Catalog No. M22628 CAS No. 104890-70-2
DMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 56 | In Stock |
|
| 5MG | 81 | In Stock |
|
| 10MG | 120 | In Stock |
|
| 25MG | 215 | In Stock |
|
| 50MG | 324 | In Stock |
|
| 100MG | 486 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDMU2139
-
NoteResearch use only, not for human use.
-
Brief DescriptionDMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).
-
DescriptionDMU2139 is a specific CYP1B1 inhibitor (CYP1B1 and CYP1A1 with IC50 of 9 nM and 795 nM, respectively).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP1B1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number104890-70-2
-
Formula Weight289.3
-
Molecular FormulaC19H15NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1ccc2cc(ccc2c1)C(=O)\C=C\c1cccnc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Horley N J , Beresford K J M , Chawla T , et al. Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines[J]. European Journal of Medicinal Chemistry, 2017, 129:159-174.
molnova catalog
related products
-
Lofemizole
Lofemizole is an antagonist of CYP1A2.
-
CYP1B1-IN-5
CYP1B1-IN-5 is a selective and potent cytochrome P450 1B1 (CYP1B1) inhibitor with an IC50 of 4.7 nM.CYP1B1-IN-5 can be used for the study of metabolism-related diseases.
-
Guan-fu base A
Guanfu base A is a potent noncompetitive CYP2D6 inhibitor (Ki: 1.20 μM in HLMs; Ki: 0.37 μM for rCYP2D6). It also inhibits HERG channel current.
